Methylprednisolone Dosing and Frequency for Acute Conditions

Standard Dosing by Condition

• The American Gastroenterological Association recommends methylprednisolone 60 mg intravenously daily as a single dose or hydrocortisone 100 mg intravenously every 6 hours (400 mg/day) for acute severe ulcerative colitis 2, 3
• The European Crohn’s and Colitis Organisation suggests that the duration of methylprednisolone treatment should be 7-10 days, as extending beyond this period provides no additional benefit and increases toxicity 2
• The American Gastroenterological Association recommends assessing response to methylprednisolone after 3 days to determine the need for salvage therapy in acute severe ulcerative colitis 2
• The National Comprehensive Cancer Network recommends methylprednisolone 1 mg/kg intravenously every 12 hours for grade 3 neurotoxicity, and 1000 mg/day intravenously for 3-5 days for grade 4 neurotoxicity, followed by rapid taper 4
• The National Comprehensive Cancer Network suggests that for refractory cases, methylprednisolone 1000 mg/day for 3 days, followed by tapering, may be effective 5
• The Society of Critical Care Medicine recommends methylprednisolone 1 mg/kg/day for early ARDS (within 7 days of onset) and 2 mg/kg/day for late persistent ARDS (after day 6 of onset) 6
• The American Thoracic Society recommends slow tapering of methylprednisolone over 13 days for ARDS 6
• The American Heart Association recommends methylprednisolone 125 mg intravenously every 6 hours for 3 days for acute asthma exacerbation 7
• The American College of Rheumatology recommends methylprednisolone dosing based on joint size for intra-articular injection in acute gout, and oral prednisone/prednisolone at 0.5 mg/kg/day for 5-10 days for systemic therapy 8

Administration Considerations

• Methylprednisolone is 5 times more potent than hydrocortisone, with 48 mg methylprednisolone equivalent to 60 mg prednisone, according to the American Association of Clinical Endocrinologists 9

Important Clinical Considerations

• Early initiation of methylprednisolone treatment (<72 hours) is associated with better outcomes and may allow for lower dosing in certain conditions, according to the Society of Critical Care Medicine 6
• The European Crohn’s and Colitis Organisation recommends that treatment duration of 7-10 days is sufficient for most acute conditions, and extending beyond this increases risk of adverse effects without additional benefit 2
• The Society of Critical Care Medicine recommends monitoring for hyperglycemia, especially in the first 36 hours following an initial bolus of methylprednisolone 6

Potential Adverse Effects

• The Society of Critical Care Medicine reports that common side effects of methylprednisolone include hyperglycemia, sleep disturbances, and increased risk of infection 6, 9
• The American Association of Clinical Endocrinologists notes that prolonged use of methylprednisolone increases risk of adrenal suppression 9
• The National Comprehensive Cancer Network recommends prophylactic antifungal therapy in patients receiving steroids for management of certain conditions 4
• The American Gastroenterological Association recommends low-molecular weight heparin prophylaxis for hospitalized patients on high-dose steroids to prevent venous thromboembolism 2